Vaccine-webfr.1

LA MISE AU POINT DE VACCINS AU CANADA

DÉJEUNER-CAUSERIE

 

Votre hôte : l’honorable sénateur Kelvin K. Ogilvie

Les conférenciers :

Sur invitation : le 1er avril 2015

Édifice du Centre, colline du Parlement

Building upon the impressive legacy of vaccines in Canada, the Health Research Caucus Luncheon on Vaccine Development in Canada will raise awareness among Parliamentarians about the fundamental approach to making vaccines, explain what they are and provide a history of vaccine development and the significant value, opportunities and challenges across the vaccine development chain in Canada

The Luncheon will also showcase PREVENT, a national Centre of Excellence for Commercialization and Research (CECR) focused on advancing Canada’s vaccine research and development by identifying promising vaccine technologies from Canadian academia and biotech and cultivating collaborative approaches to optimize their transition into attractive candidates for commercialization.

Finally, the event will profile the development of the experimental VSV-EBOV vaccine, developed by researchers at the Public Health Agency of Canada’s National Microbiology Laboratory (NML).